Crude Oil Gains 1%; Macy's Reports Strong Q3 Results

Benzinga12-04 01:21

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 250 points on Wednesday.

The Dow traded up 0.61% to 47,765.87 while the NASDAQ rose 0.07% to 23,430.56. The S&P 500 also rose, gaining, 0.22% to 6,844.57.

Check This Out: How To Earn $500 A Month From Dollar General Stock Ahead Of Q3 Earnings

Leading and Lagging SectorsEnergy shares jumped by 1.2% on Wednesday.

In trading on Wednesday, information technology stocks fell by 0.6%.

Top Headline

Macy's Inc (NYSE:M) posted better-than-expected sales and profit for the third quarter.

The firm reported quarterly sales of $4.713 billion (down 0.6% year over year), beating the Street view of $4.621 billion. The company reported third-quarter adjusted earnings per share of 9 cents.

Equities Trading UP           

  • Capricor Therapeutics, Inc. (NASDAQ:CAPR) shares shot up 291% to $24.87. The company announced topline results from its Phase 3 HOPE-3 Trial evaluating deramiocel cell therapy for Duchenne Muscular Dystrophy met its primary endpoint and secondary cardiac endpoint.
  • Shares of Virax Biolabs Group Limited (NASDAQ:VRAX) got a boost, surging 71% to $0.6709 after the company announced clinical progress and intends to report clinical data from its UK PAIS trial in 2026.
  • Aeva Technologies, Inc. (NASDAQ:AEVA) shares were also up, gaining 16% to $12.58 after the company announced it was selected by a Top European Passenger OEM as its exclusive LiDAR supplier for its global series-production vehicle platform to enable Level 3 automated driving.

Equities Trading DOWN

  • CIMG Inc. (NASDAQ:IMG) shares dropped 35% to $0.1200 after the company announced a 20-for-1 reverse stock split.
  • Shares of ADC Therapeutics SA (NYSE:ADCT) were down 29% to $3.2499 after the company reported updated data from its LOTIS-7 trial evaluating Zynlonta in combination with Glofitamab in relapsed/refractory DLBCL patients.
  • Pure Storage, Inc. (NYSE:PSTG) was down, falling 26% to $69.99 following third-quarter results.

CommoditiesIn commodity news, oil traded up 1% to $59.21 while gold traded up 0.6% at $4,246.90.

Silver traded up 0.4% to $58.935 on Wednesday, while copper rose 3% to $5.4000.

Euro zone

European shares were mostly higher today. The eurozone's STOXX 600 rose 0.16%, while Spain's IBEX 35 Index rose 1.55%. London's FTSE 100 fell 0.02%, Germany's DAX 40 gained 0.08% and France's CAC 40 rose 0.09% during the session.

Asia Pacific Markets

Asian markets closed mixed on Wednesday, with Japan's Nikkei gaining 1.14%, Hong Kong's Hang Seng falling 1.28%, China's Shanghai Composite falling 0.51% and India's BSE Sensex falling 0.04%.

Economics

  • The S&P Global services PMI declined to 54.1 in November from 54.8 in the prior month, and revised lower from the preliminary reading of 55.
  • The S&P Global composite PMI fell to 54.2 in November from 54.6 in the previous month and down from the preliminary level of 54.8.
  • U.S. industrial production increased 0.1% month-over-month in September compared to a revised 0.3% decline in August.
  • Private businesses in the U.S. lowered 32,000 jobs in November compared to a revised 47,000 gain in the previous month.
  • U.S. crude oil inventories rose by 0.574 million barrels in the week ending Nov. 28, compared to a 2.774 million barrel gain in the previous week.

Now Read This:

  • Top 2 Industrials Stocks That May Fall Off A Cliff This Quarter

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment